SCHEMBL6920855

SCHEMBL6920855

CC(C(N)=O)C(=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.53
▸ ADRA2A P08913 1/20 0.53
▸ ADRA2B P18089 1/20 0.53
▸ HTR2A P28223 1/20 0.53
▸ HRH1 P35367 1/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ KMT2A Q03164 2/20 0.51
▸ LMNA P02545 4/20 0.50
▸ MAPT P10636 3/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ POLB P06746 1/20 0.50
▸ PARP1 P09874 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1397470 0.86 KMT2A (0.58) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL8823334 0.82 KMT2A (0.55) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL20944778 0.82 KMT2A (0.55) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL649287 0.82 KMT2A (0.55) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL3274886 0.82 KMT2A (0.55) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL28458281 0.80 KMT2A (0.53) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL580136 0.79 TDP1 (0.46) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL11408880 0.78 KMT2A (0.51) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL6578238 0.78 KMT2A (0.51) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL6578234 0.78 KMT2A (0.51) PGRADRA2AADRA2BHTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103059215-A Glycine betaine ester intelligent hydrogel relatively controllable in structure and preparation method and application UNIV SOUTH CHINA TECH 2013-04-24 — — CN claimed
CN-107548397-A Kv1.3 inhibitors and medical uses thereof 4SC股份公司 2018-01-05 — — CN disclosed
CN-107548396-A Kv1.3 inhibitors and medical uses thereof 4SC股份公司 2018-01-05 — — CN disclosed
CN-103059215-A Glycine betaine ester intelligent hydrogel relatively controllable in structure and preparation method and application UNIV SOUTH CHINA TECH 2013-04-24 — — CN disclosed
EP-1370515-A2 SYNTHESIS OF N,N-DIMETHYL-3-(4-METHYL) BENZOYL PROPIONAMIDE, A KEY INTERMEDIATE OF ZOLPIDEM RANBAXY LABORATORIES, LTD. (IN) 2003-12-17 — — EP disclosed
WO-2002018303-A3 SYNTHESIS OF N,N-DIMETHYL-3-(4-METHYL) BENZOYL PROPIONAMIDE, A KEY INTERMEDIATE OF ZOLPIDEM RANBAXY LAB LTD (IN) 2003-10-02 — — WO disclosed
EP-1320531-A2 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2003-06-25 — — EP disclosed
US-6414013-B1 KINASE INHIBITORS; ANTICANCER AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2002-07-02 — — US disclosed
WO-2002018303-A2 SYNTHESIS OF N,N-DIMETHYL-3-(4-METHYL) BENZOYL PROPIONAMIDE, A KEY INTERMEDIATE OF ZOLPIDEM RANBAXY LABORATORIES LIMITED (IN) 2002-03-07 — — WO disclosed
WO-2002012242-A2 BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2002-02-14 — — WO disclosed
EP-0300325-A2 Compositions for promoting growth of animals COMETEC S.r.l. (IT) 1989-01-25 — — EP disclosed
US-3936468-A PSYCHOTROPIC SUMITOMO CHEMICAL COMPANY, LTD. (JA) 1976-02-03 — — US disclosed
US-3936468-A PSYCHOTROPIC SUMITOMO CHEMICAL COMPANY, LTD. (JA) 1976-02-03 — — US disclosed
Send feedback